Skip to main content
Top
Published in: BMC Cancer 1/2005

Open Access 01-12-2005 | Research article

Absence of pathogenic mitochondrial DNA mutations in mouse brain tumors

Authors: Michael A Kiebish, Thomas N Seyfried

Published in: BMC Cancer | Issue 1/2005

Login to get access

Abstract

Background

Somatic mutations in the mitochondrial genome occur in numerous tumor types including brain tumors. These mutations are generally found in the hypervariable regions I and II of the displacement loop and unlikely alter mitochondrial function. Two hypervariable regions of mononucleotide repeats occur in the mouse mitochondrial genome, i.e., the origin of replication of the light strand (OL) and the Arg tRNA.

Methods

In this study we examined the entire mitochondrial genome in a series of chemically induced brain tumors in the C57BL/6J strain and spontaneous brain tumors in the VM mouse strain. The tumor mtDNA was compared to that of mtDNA in brain mitochondrial populations from the corresponding syngeneic mouse host strain.

Results

Direct sequencing revealed a few homoplasmic base pair insertions, deletions, and substitutions in the tumor cells mainly in regions of mononucleotide repeats. A heteroplasmic mutation in the 16srRNA gene was detected in a spontaneous metastatic VM brain tumor.

Conclusion

None of the mutations were considered pathogenic, indicating that mtDNA somatic mutations do not likely contribute to the initiation or progression of these diverse mouse brain tumors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wolstenholme DR: Animal mitochondrial DNA: structure and evolution. Int Rev Cytol. 1992, 141: 173-216.CrossRefPubMed Wolstenholme DR: Animal mitochondrial DNA: structure and evolution. Int Rev Cytol. 1992, 141: 173-216.CrossRefPubMed
2.
go back to reference Barrell BG, Bankier AT, Drouin J: A different genetic code in human mitochondria. Nature. 1979, 282: 189-194. 10.1038/282189a0.CrossRefPubMed Barrell BG, Bankier AT, Drouin J: A different genetic code in human mitochondria. Nature. 1979, 282: 189-194. 10.1038/282189a0.CrossRefPubMed
3.
go back to reference Neckelmann N, Li K, Wade RP, Shuster R, Wallace DC: cDNA sequence of a human skeletal muscle ADP/ATP translocator: lack of a leader peptide, divergence from a fibroblast translocator cDNA, and coevolution with mitochondrial DNA genes. Proc Natl Acad Sci U S A. 1987, 84: 7580-7584.CrossRefPubMedPubMedCentral Neckelmann N, Li K, Wade RP, Shuster R, Wallace DC: cDNA sequence of a human skeletal muscle ADP/ATP translocator: lack of a leader peptide, divergence from a fibroblast translocator cDNA, and coevolution with mitochondrial DNA genes. Proc Natl Acad Sci U S A. 1987, 84: 7580-7584.CrossRefPubMedPubMedCentral
4.
go back to reference Wallace DC, Ye JH, Neckelmann SN, Singh G, Webster KA, Greenberg BD: Sequence analysis of cDNAs for the human and bovine ATP synthase beta subunit: mitochondrial DNA genes sustain seventeen times more mutations. Curr Genet. 1987, 12: 81-90. 10.1007/BF00434661.CrossRefPubMed Wallace DC, Ye JH, Neckelmann SN, Singh G, Webster KA, Greenberg BD: Sequence analysis of cDNAs for the human and bovine ATP synthase beta subunit: mitochondrial DNA genes sustain seventeen times more mutations. Curr Genet. 1987, 12: 81-90. 10.1007/BF00434661.CrossRefPubMed
5.
go back to reference Backer JM, Weinstein IB: Mitochondrial DNA is a major cellular target for a dihydrodiol-epoxide derivative of benzo[a]pyrene. Science. 1980, 209: 297-299.CrossRefPubMed Backer JM, Weinstein IB: Mitochondrial DNA is a major cellular target for a dihydrodiol-epoxide derivative of benzo[a]pyrene. Science. 1980, 209: 297-299.CrossRefPubMed
6.
go back to reference Allen JA, Coombs MM: Covalent binding of polycyclic aromatic compounds to mitochondrial and nuclear DNA. Nature. 1980, 287: 244-245. 10.1038/287244a0.CrossRefPubMed Allen JA, Coombs MM: Covalent binding of polycyclic aromatic compounds to mitochondrial and nuclear DNA. Nature. 1980, 287: 244-245. 10.1038/287244a0.CrossRefPubMed
8.
go back to reference Croteau DL, Bohr VA: Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem. 1997, 272: 25409-25412. 10.1074/jbc.272.41.25409.CrossRefPubMed Croteau DL, Bohr VA: Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem. 1997, 272: 25409-25412. 10.1074/jbc.272.41.25409.CrossRefPubMed
9.
go back to reference Bianchi NO, Bianchi MS, Richard SM: Mitochondrial genome instability in human cancers. Mutat Res. 2001, 488: 9-23. 10.1016/S1383-5742(00)00063-6.CrossRefPubMed Bianchi NO, Bianchi MS, Richard SM: Mitochondrial genome instability in human cancers. Mutat Res. 2001, 488: 9-23. 10.1016/S1383-5742(00)00063-6.CrossRefPubMed
11.
go back to reference Cavalli LR, Liang BC: Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved?. Mutat Res. 1998, 398: 19-26.CrossRefPubMed Cavalli LR, Liang BC: Mutagenesis, tumorigenicity, and apoptosis: are the mitochondria involved?. Mutat Res. 1998, 398: 19-26.CrossRefPubMed
12.
go back to reference Augenlicht LH, Heerdt BG: Mitochondria: integrators in tumorigenesis?. Nat Genet. 2001, 28: 104-105. 10.1038/88800.CrossRefPubMed Augenlicht LH, Heerdt BG: Mitochondria: integrators in tumorigenesis?. Nat Genet. 2001, 28: 104-105. 10.1038/88800.CrossRefPubMed
13.
go back to reference Tan DJ, Bai RK, Wong LJ: Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 2002, 62: 972-976.PubMed Tan DJ, Bai RK, Wong LJ: Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 2002, 62: 972-976.PubMed
14.
go back to reference Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J, Sidransky D: Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science. 2000, 287: 2017-2019. 10.1126/science.287.5460.2017.CrossRefPubMed Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J, Sidransky D: Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science. 2000, 287: 2017-2019. 10.1126/science.287.5460.2017.CrossRefPubMed
15.
go back to reference Maximo V, Soares P, Seruca R, Rocha AS, Castro P, Sobrinho-Simoes M: Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma. Genes Chromosomes Cancer. 2001, 32: 136-143. 10.1002/gcc.1175.CrossRefPubMed Maximo V, Soares P, Seruca R, Rocha AS, Castro P, Sobrinho-Simoes M: Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma. Genes Chromosomes Cancer. 2001, 32: 136-143. 10.1002/gcc.1175.CrossRefPubMed
16.
go back to reference Hibi K, Nakayama H, Yamazaki T, Takase T, Taguchi M, Kasai Y, Ito K, Akiyama S, Nakao A: Mitochondrial DNA alteration in esophageal cancer. Int J Cancer. 2001, 92: 319-321. 10.1002/ijc.1204.CrossRefPubMed Hibi K, Nakayama H, Yamazaki T, Takase T, Taguchi M, Kasai Y, Ito K, Akiyama S, Nakao A: Mitochondrial DNA alteration in esophageal cancer. Int J Cancer. 2001, 92: 319-321. 10.1002/ijc.1204.CrossRefPubMed
17.
go back to reference Jones JB, Song JJ, Hempen PM, Parmigiani G, Hruban RH, Kern SE: Detection of mitochondrial DNA mutations in pancreatic cancer offers a "mass"-ive advantage over detection of nuclear DNA mutations. Cancer Res. 2001, 61: 1299-1304.PubMed Jones JB, Song JJ, Hempen PM, Parmigiani G, Hruban RH, Kern SE: Detection of mitochondrial DNA mutations in pancreatic cancer offers a "mass"-ive advantage over detection of nuclear DNA mutations. Cancer Res. 2001, 61: 1299-1304.PubMed
18.
go back to reference Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, Trush MA, Kinzler KW, Vogelstein B: Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet. 1998, 20: 291-293. 10.1038/3108.CrossRefPubMed Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, Trush MA, Kinzler KW, Vogelstein B: Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet. 1998, 20: 291-293. 10.1038/3108.CrossRefPubMed
19.
go back to reference Okochi O, Hibi K, Uemura T, Inoue S, Takeda S, Kaneko T, Nakao A: Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients. Clin Cancer Res. 2002, 8: 2875-2878.PubMed Okochi O, Hibi K, Uemura T, Inoue S, Takeda S, Kaneko T, Nakao A: Detection of mitochondrial DNA alterations in the serum of hepatocellular carcinoma patients. Clin Cancer Res. 2002, 8: 2875-2878.PubMed
20.
go back to reference Ha PK, Tong BC, Westra WH, Sanchez-Cespedes M, Parrella P, Zahurak M, Sidransky D, Califano JA: Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation. Clin Cancer Res. 2002, 8: 2260-2265.PubMed Ha PK, Tong BC, Westra WH, Sanchez-Cespedes M, Parrella P, Zahurak M, Sidransky D, Califano JA: Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation. Clin Cancer Res. 2002, 8: 2260-2265.PubMed
21.
go back to reference Kumimoto H, Yamane Y, Nishimoto Y, Fukami H, Shinoda M, Hatooka S, Ishizaki K: Frequent somatic mutations of mitochondrial DNA in esophageal squamous cell carcinoma. Int J Cancer. 2004, 108: 228-231. 10.1002/ijc.11564.CrossRefPubMed Kumimoto H, Yamane Y, Nishimoto Y, Fukami H, Shinoda M, Hatooka S, Ishizaki K: Frequent somatic mutations of mitochondrial DNA in esophageal squamous cell carcinoma. Int J Cancer. 2004, 108: 228-231. 10.1002/ijc.11564.CrossRefPubMed
22.
go back to reference Sanchez-Cespedes M, Parrella P, Nomoto S, Cohen D, Xiao Y, Esteller M, Jeronimo C, Jordan RC, Nicol T, Koch WM, Schoenberg M, Mazzarelli P, Fazio VM, Sidransky D: Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res. 2001, 61: 7015-7019.PubMed Sanchez-Cespedes M, Parrella P, Nomoto S, Cohen D, Xiao Y, Esteller M, Jeronimo C, Jordan RC, Nicol T, Koch WM, Schoenberg M, Mazzarelli P, Fazio VM, Sidransky D: Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Res. 2001, 61: 7015-7019.PubMed
23.
go back to reference Bayona-Bafaluy MP, Acin-Perez R, Mullikin JC, Park JS, Moreno-Loshuertos R, Hu P, Perez-Martos A, Fernandez-Silva P, Bai Y, Enriquez JA: Revisiting the mouse mitochondrial DNA sequence. Nucleic Acids Res. 2003, 31: 5349-5355. 10.1093/nar/gkg739.CrossRefPubMedPubMedCentral Bayona-Bafaluy MP, Acin-Perez R, Mullikin JC, Park JS, Moreno-Loshuertos R, Hu P, Perez-Martos A, Fernandez-Silva P, Bai Y, Enriquez JA: Revisiting the mouse mitochondrial DNA sequence. Nucleic Acids Res. 2003, 31: 5349-5355. 10.1093/nar/gkg739.CrossRefPubMedPubMedCentral
25.
go back to reference Warburg O: The Metabolism of Tumours. 1931, New York, Richard R. Smith Inc., 327- Warburg O: The Metabolism of Tumours. 1931, New York, Richard R. Smith Inc., 327-
26.
go back to reference Shay JW, Werbin H: Are mitochondrial DNA mutations involved in the carcinogenic process?. Mutat Res. 1987, 186: 149-160.CrossRefPubMed Shay JW, Werbin H: Are mitochondrial DNA mutations involved in the carcinogenic process?. Mutat Res. 1987, 186: 149-160.CrossRefPubMed
27.
go back to reference Baggetto LG: Role of mitochondria in carcinogenesis. Eur J Cancer. 1992, 29A: 156-159.PubMed Baggetto LG: Role of mitochondria in carcinogenesis. Eur J Cancer. 1992, 29A: 156-159.PubMed
28.
go back to reference Cavalli LR, Varella-Garcia M, Liang BC: Diminished tumorigenic phenotype after depletion of mitochondrial DNA. Cell Growth Differ. 1997, 8: 1189-1198.PubMed Cavalli LR, Varella-Garcia M, Liang BC: Diminished tumorigenic phenotype after depletion of mitochondrial DNA. Cell Growth Differ. 1997, 8: 1189-1198.PubMed
29.
go back to reference Kirches E, Michael M, Woy C, Schneider T, Warich-Kirches M, Schneider-Stock R, Winkler K, Wittig H, Dietzmann K: Loss of heteroplasmy in the displacement loop of brain mitochondrial DNA in astrocytic tumors. Genes Chromosomes Cancer. 1999, 26: 80-83. 10.1002/(SICI)1098-2264(199909)26:1<80::AID-GCC11>3.0.CO;2-4.CrossRefPubMed Kirches E, Michael M, Woy C, Schneider T, Warich-Kirches M, Schneider-Stock R, Winkler K, Wittig H, Dietzmann K: Loss of heteroplasmy in the displacement loop of brain mitochondrial DNA in astrocytic tumors. Genes Chromosomes Cancer. 1999, 26: 80-83. 10.1002/(SICI)1098-2264(199909)26:1<80::AID-GCC11>3.0.CO;2-4.CrossRefPubMed
30.
go back to reference Kirches E, Krause G, Warich-Kirches M, Weis S, Schneider T, Meyer-Puttlitz B, Mawrin C, Dietzmann K: High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int J Cancer. 2001, 93: 534-538. 10.1002/ijc.1375.CrossRefPubMed Kirches E, Krause G, Warich-Kirches M, Weis S, Schneider T, Meyer-Puttlitz B, Mawrin C, Dietzmann K: High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int J Cancer. 2001, 93: 534-538. 10.1002/ijc.1375.CrossRefPubMed
31.
go back to reference Kirches E, Mawrin C, Schneider-Stock R, Krause G, Scherlach C, Dietzmann K: Mitochondrial DNA as a clonal tumor cell marker: gliomatosis cerebri. J Neurooncol. 2003, 61: 1-5. 10.1023/A:1021296212233.CrossRefPubMed Kirches E, Mawrin C, Schneider-Stock R, Krause G, Scherlach C, Dietzmann K: Mitochondrial DNA as a clonal tumor cell marker: gliomatosis cerebri. J Neurooncol. 2003, 61: 1-5. 10.1023/A:1021296212233.CrossRefPubMed
32.
go back to reference Vega A, Salas A, Gamborino E, Sobrido MJ, Macaulay V, Carracedo A: mtDNA mutations in tumors of the central nervous system reflect the neutral evolution of mtDNA in populations. Oncogene. 2004, 23: 1314-1320. 10.1038/sj.onc.1207214.CrossRefPubMed Vega A, Salas A, Gamborino E, Sobrido MJ, Macaulay V, Carracedo A: mtDNA mutations in tumors of the central nervous system reflect the neutral evolution of mtDNA in populations. Oncogene. 2004, 23: 1314-1320. 10.1038/sj.onc.1207214.CrossRefPubMed
33.
go back to reference Kurtz A, Lueth M, Kluwe L, Zhang T, Foster R, Mautner VF, Hartmann M, Tan DJ, Martuza RL, Friedrich RE, Driever PH, Wong LJ: Somatic mitochondrial DNA mutations in neurofibromatosis type 1-associated tumors. Mol Cancer Res. 2004, 2: 433-441.PubMed Kurtz A, Lueth M, Kluwe L, Zhang T, Foster R, Mautner VF, Hartmann M, Tan DJ, Martuza RL, Friedrich RE, Driever PH, Wong LJ: Somatic mitochondrial DNA mutations in neurofibromatosis type 1-associated tumors. Mol Cancer Res. 2004, 2: 433-441.PubMed
34.
go back to reference Liang BC, Hays L: Mitochondrial DNA copy number changes in human gliomas. Cancer Lett. 1996, 105: 167-173. 10.1016/0304-3835(96)04276-0.CrossRefPubMed Liang BC, Hays L: Mitochondrial DNA copy number changes in human gliomas. Cancer Lett. 1996, 105: 167-173. 10.1016/0304-3835(96)04276-0.CrossRefPubMed
35.
go back to reference Wong LJ, Lueth M, Li XN, Lau CC, Vogel H: Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. Cancer Res. 2003, 63: 3866-3871.PubMed Wong LJ, Lueth M, Li XN, Lau CC, Vogel H: Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. Cancer Res. 2003, 63: 3866-3871.PubMed
36.
go back to reference Akimoto M, Niikura M, Ichikawa M, Yonekawa H, Nakada K, Honma Y, Hayashi J: Nuclear DNA but not mtDNA controls tumor phenotypes in mouse cells. Biochem Biophys Res Commun. 2005, 327: 1028-1035. 10.1016/j.bbrc.2004.12.105.CrossRefPubMed Akimoto M, Niikura M, Ichikawa M, Yonekawa H, Nakada K, Honma Y, Hayashi J: Nuclear DNA but not mtDNA controls tumor phenotypes in mouse cells. Biochem Biophys Res Commun. 2005, 327: 1028-1035. 10.1016/j.bbrc.2004.12.105.CrossRefPubMed
37.
go back to reference Battino M, Gorini A, Villa RF, Genova ML, Bovina C, Sassi S, Littarru GP, Lenaz G: Coenzyme Q content in synaptic and non-synaptic mitochondria from different brain regions in the ageing rat. Mech Ageing Dev. 1995, 78: 173-187. 10.1016/0047-6374(94)01535-T.CrossRefPubMed Battino M, Gorini A, Villa RF, Genova ML, Bovina C, Sassi S, Littarru GP, Lenaz G: Coenzyme Q content in synaptic and non-synaptic mitochondria from different brain regions in the ageing rat. Mech Ageing Dev. 1995, 78: 173-187. 10.1016/0047-6374(94)01535-T.CrossRefPubMed
38.
go back to reference Genova ML, Bovina C, Marchetti M, Pallotti F, Tietz C, Biagini G, Pugnaloni A, Viticchi C, Gorini A, Villa RF, Lenaz G: Decrease of rotenone inhibition is a sensitive parameter of complex I damage in brain non-synaptic mitochondria of aged rats. FEBS Lett. 1997, 410: 467-469. 10.1016/S0014-5793(97)00638-8.CrossRefPubMed Genova ML, Bovina C, Marchetti M, Pallotti F, Tietz C, Biagini G, Pugnaloni A, Viticchi C, Gorini A, Villa RF, Lenaz G: Decrease of rotenone inhibition is a sensitive parameter of complex I damage in brain non-synaptic mitochondria of aged rats. FEBS Lett. 1997, 410: 467-469. 10.1016/S0014-5793(97)00638-8.CrossRefPubMed
39.
go back to reference Lai JC: Oxidative metabolism in neuronal and non-neuronal mitochondria. Can J Physiol Pharmacol. 1992, 70 Suppl: S130-7.CrossRefPubMed Lai JC: Oxidative metabolism in neuronal and non-neuronal mitochondria. Can J Physiol Pharmacol. 1992, 70 Suppl: S130-7.CrossRefPubMed
40.
go back to reference Trounce I, Schmiedel J, Yen HC, Hosseini S, Brown MD, Olson JJ, Wallace DC: Cloning of neuronal mtDNA variants in cultured cells by synaptosome fusion with mtDNA-less cells. Nucleic Acids Res. 2000, 28: 2164-2170. 10.1093/nar/28.10.2164.CrossRefPubMedPubMedCentral Trounce I, Schmiedel J, Yen HC, Hosseini S, Brown MD, Olson JJ, Wallace DC: Cloning of neuronal mtDNA variants in cultured cells by synaptosome fusion with mtDNA-less cells. Nucleic Acids Res. 2000, 28: 2164-2170. 10.1093/nar/28.10.2164.CrossRefPubMedPubMedCentral
41.
go back to reference Ranes MK, El-Abbadi M, Manfredi MG, Mukherjee P, Platt FM, Seyfried TN: N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours. Br J Cancer. 2001, 84: 1107-1114. 10.1054/bjoc.2000.1713.CrossRefPubMedPubMedCentral Ranes MK, El-Abbadi M, Manfredi MG, Mukherjee P, Platt FM, Seyfried TN: N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours. Br J Cancer. 2001, 84: 1107-1114. 10.1054/bjoc.2000.1713.CrossRefPubMedPubMedCentral
42.
go back to reference Seyfried TN, el-Abbadi M, Roy ML: Ganglioside distribution in murine neural tumors. Mol Chem Neuropathol. 1992, 17: 147-167.CrossRefPubMed Seyfried TN, el-Abbadi M, Roy ML: Ganglioside distribution in murine neural tumors. Mol Chem Neuropathol. 1992, 17: 147-167.CrossRefPubMed
43.
go back to reference Zimmerman HM, Arnould H: Experimental brain tumors: I. Tumors produced with methylcholanthrene. Cancer Res. 1941, 1: 919-938. Zimmerman HM, Arnould H: Experimental brain tumors: I. Tumors produced with methylcholanthrene. Cancer Res. 1941, 1: 919-938.
44.
go back to reference Rubin R, Sutton C: The ultrastructure of the mouse ependymoblastoma and its contained virus-like particles. J Neuropathol Exp Neurol. 1968, 27: 136-CrossRefPubMed Rubin R, Sutton C: The ultrastructure of the mouse ependymoblastoma and its contained virus-like particles. J Neuropathol Exp Neurol. 1968, 27: 136-CrossRefPubMed
45.
go back to reference Mukherjee P, El-Abbadi MM, Kasperzyk JL, Ranes MK, Seyfried TN: Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. Br J Cancer. 2002, 86: 1615-1621. 10.1038/sj.bjc.6600298.CrossRefPubMedPubMedCentral Mukherjee P, El-Abbadi MM, Kasperzyk JL, Ranes MK, Seyfried TN: Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. Br J Cancer. 2002, 86: 1615-1621. 10.1038/sj.bjc.6600298.CrossRefPubMedPubMedCentral
46.
go back to reference Mukherjee P, Abate LE, Seyfried TN: Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. Clin Cancer Res. 2004, 10: 5622-5629.CrossRefPubMed Mukherjee P, Abate LE, Seyfried TN: Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. Clin Cancer Res. 2004, 10: 5622-5629.CrossRefPubMed
47.
go back to reference Manfredi MG, Lim S, Claffey KP, Seyfried TN: Gangliosides influence angiogenesis in an experimental mouse brain tumor. Cancer Res. 1999, 59: 5392-5397.PubMed Manfredi MG, Lim S, Claffey KP, Seyfried TN: Gangliosides influence angiogenesis in an experimental mouse brain tumor. Cancer Res. 1999, 59: 5392-5397.PubMed
48.
go back to reference Seyfried TN, Yu RK, Saito M, Albert M: Ganglioside composition of an experimental mouse brain tumor. Cancer Res. 1987, 47: 3538-3542.PubMed Seyfried TN, Yu RK, Saito M, Albert M: Ganglioside composition of an experimental mouse brain tumor. Cancer Res. 1987, 47: 3538-3542.PubMed
49.
go back to reference Cotterchio M, Seyfried TN: The influence of ImuVert, a biological response modifier, on the growth and ganglioside composition of murine neural tumors. Mol Chem Neuropathol. 1993, 20: 163-172.CrossRefPubMed Cotterchio M, Seyfried TN: The influence of ImuVert, a biological response modifier, on the growth and ganglioside composition of murine neural tumors. Mol Chem Neuropathol. 1993, 20: 163-172.CrossRefPubMed
50.
go back to reference Fraser H: Brain tumours in mice, with particular reference to astrocytoma. Food Chem Toxicol. 1986, 24: 105-111. 10.1016/0278-6915(86)90344-3.CrossRefPubMed Fraser H: Brain tumours in mice, with particular reference to astrocytoma. Food Chem Toxicol. 1986, 24: 105-111. 10.1016/0278-6915(86)90344-3.CrossRefPubMed
51.
go back to reference El-Abbadi M, Seyfried TN, Yates AJ, Orosz C, Lee MC: Ganglioside composition and histology of a spontaneous metastatic brain tumour in the VM mouse. Br J Cancer. 2001, 85: 285-292. 10.1054/bjoc.2001.1909.CrossRefPubMedPubMedCentral El-Abbadi M, Seyfried TN, Yates AJ, Orosz C, Lee MC: Ganglioside composition and histology of a spontaneous metastatic brain tumour in the VM mouse. Br J Cancer. 2001, 85: 285-292. 10.1054/bjoc.2001.1909.CrossRefPubMedPubMedCentral
52.
go back to reference Bai H, Seyfried TN: Influence of ganglioside GM3 and high density lipoprotein on the cohesion of mouse brain tumor cells. J Lipid Res. 1997, 38: 160-172.PubMed Bai H, Seyfried TN: Influence of ganglioside GM3 and high density lipoprotein on the cohesion of mouse brain tumor cells. J Lipid Res. 1997, 38: 160-172.PubMed
53.
go back to reference el-Abbadi M, Seyfried TN: Influence of growth environment on the ganglioside composition of an experimental mouse brain tumor. Mol Chem Neuropathol. 1994, 21: 273-285.CrossRefPubMed el-Abbadi M, Seyfried TN: Influence of growth environment on the ganglioside composition of an experimental mouse brain tumor. Mol Chem Neuropathol. 1994, 21: 273-285.CrossRefPubMed
54.
go back to reference Pon LA, Schon EA: Mitochondria. Methods in Cell Biology. Edited by: Wilson L and Matsudaira P. 2001, , Academic Press, 65: 20-23. Pon LA, Schon EA: Mitochondria. Methods in Cell Biology. Edited by: Wilson L and Matsudaira P. 2001, , Academic Press, 65: 20-23.
55.
go back to reference Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997, 275: 1129-1132. 10.1126/science.275.5303.1129.CrossRefPubMed Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 1997, 275: 1129-1132. 10.1126/science.275.5303.1129.CrossRefPubMed
56.
go back to reference Bibb MJ, Van Etten RA, Wright CT, Walberg MW, Clayton DA: Sequence and gene organization of mouse mitochondrial DNA. Cell. 1981, 26: 167-180. 10.1016/0092-8674(81)90300-7.CrossRefPubMed Bibb MJ, Van Etten RA, Wright CT, Walberg MW, Clayton DA: Sequence and gene organization of mouse mitochondrial DNA. Cell. 1981, 26: 167-180. 10.1016/0092-8674(81)90300-7.CrossRefPubMed
57.
go back to reference Heerdt BG, Chen J, Stewart LR, Augenlicht LH: Polymorphisms, but lack of mutations or instability, in the promotor region of the mitochondrial genome in human colonic tumors. Cancer Res. 1994, 54: 3912-3915.PubMed Heerdt BG, Chen J, Stewart LR, Augenlicht LH: Polymorphisms, but lack of mutations or instability, in the promotor region of the mitochondrial genome in human colonic tumors. Cancer Res. 1994, 54: 3912-3915.PubMed
58.
go back to reference Parfait B, Rustin P, Munnich A, Rotig A: Co-amplification of nuclear pseudogenes and assessment of heteroplasmy of mitochondrial DNA mutations. Biochem Biophys Res Commun. 1998, 247: 57-59. 10.1006/bbrc.1998.8666.CrossRefPubMed Parfait B, Rustin P, Munnich A, Rotig A: Co-amplification of nuclear pseudogenes and assessment of heteroplasmy of mitochondrial DNA mutations. Biochem Biophys Res Commun. 1998, 247: 57-59. 10.1006/bbrc.1998.8666.CrossRefPubMed
59.
go back to reference Ecsedy JA, Yohe HC, Bergeron AJ, Seyfried TN: Tumor-infiltrating macrophages influence the glycosphingolipid composition of murine brain tumors. J Lipid Res. 1998, 39: 2218-2227.PubMed Ecsedy JA, Yohe HC, Bergeron AJ, Seyfried TN: Tumor-infiltrating macrophages influence the glycosphingolipid composition of murine brain tumors. J Lipid Res. 1998, 39: 2218-2227.PubMed
60.
go back to reference Meixensberger J, Herting B, Roggendorf W, Reichmann H: Metabolic patterns in malignant gliomas. J Neurooncol. 1995, 24: 153-161. 10.1007/BF01078485.CrossRefPubMed Meixensberger J, Herting B, Roggendorf W, Reichmann H: Metabolic patterns in malignant gliomas. J Neurooncol. 1995, 24: 153-161. 10.1007/BF01078485.CrossRefPubMed
61.
go back to reference Pedersen PL: Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res. 1978, 22: 190-274.CrossRefPubMed Pedersen PL: Tumor mitochondria and the bioenergetics of cancer cells. Prog Exp Tumor Res. 1978, 22: 190-274.CrossRefPubMed
62.
go back to reference Cuezva JM, Chen G, Alonso AM, Isidoro A, Misek DE, Hanash SM, Beer DG: The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis. 2004, 25: 1157-1163. 10.1093/carcin/bgh113.CrossRefPubMed Cuezva JM, Chen G, Alonso AM, Isidoro A, Misek DE, Hanash SM, Beer DG: The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis. Carcinogenesis. 2004, 25: 1157-1163. 10.1093/carcin/bgh113.CrossRefPubMed
63.
go back to reference Floridi A, Paggi MG, Fanciulli M: Modulation of glycolysis in neuroepithelial tumors. J Neurosurg Sci. 1989, 33: 55-64.PubMed Floridi A, Paggi MG, Fanciulli M: Modulation of glycolysis in neuroepithelial tumors. J Neurosurg Sci. 1989, 33: 55-64.PubMed
64.
go back to reference Mangiardi JR, Yodice P: Metabolism of the malignant astrocytoma. Neurosurgery. 1990, 26: 1-19. 10.1097/00006123-199001000-00001.CrossRefPubMed Mangiardi JR, Yodice P: Metabolism of the malignant astrocytoma. Neurosurgery. 1990, 26: 1-19. 10.1097/00006123-199001000-00001.CrossRefPubMed
65.
go back to reference Ikezaki K, Black KL, Conklin SG, Becker DP: Histochemical evaluation of energy metabolism in rat glioma. Neurol Res. 1992, 14: 289-293.PubMed Ikezaki K, Black KL, Conklin SG, Becker DP: Histochemical evaluation of energy metabolism in rat glioma. Neurol Res. 1992, 14: 289-293.PubMed
66.
go back to reference Aisenberg AC: The Glycolysis and Respiration of Tumors. 1961, New York, Academic Press, 224- Aisenberg AC: The Glycolysis and Respiration of Tumors. 1961, New York, Academic Press, 224-
67.
go back to reference Jazin EE, Cavelier L, Eriksson I, Oreland L, Gyllensten U: Human brain contains high levels of heteroplasmy in the noncoding regions of mitochondrial DNA. Proc Natl Acad Sci U S A. 1996, 93: 12382-12387. 10.1073/pnas.93.22.12382.CrossRefPubMedPubMedCentral Jazin EE, Cavelier L, Eriksson I, Oreland L, Gyllensten U: Human brain contains high levels of heteroplasmy in the noncoding regions of mitochondrial DNA. Proc Natl Acad Sci U S A. 1996, 93: 12382-12387. 10.1073/pnas.93.22.12382.CrossRefPubMedPubMedCentral
68.
go back to reference Taylor RW, Taylor GA, Durham SE, Turnbull DM: The determination of complete human mitochondrial DNA sequences in single cells: implications for the study of somatic mitochondrial DNA point mutations. Nucleic Acids Res. 2001, 29: E74-4. 10.1093/nar/29.15.e74.CrossRefPubMedPubMedCentral Taylor RW, Taylor GA, Durham SE, Turnbull DM: The determination of complete human mitochondrial DNA sequences in single cells: implications for the study of somatic mitochondrial DNA point mutations. Nucleic Acids Res. 2001, 29: E74-4. 10.1093/nar/29.15.e74.CrossRefPubMedPubMedCentral
Metadata
Title
Absence of pathogenic mitochondrial DNA mutations in mouse brain tumors
Authors
Michael A Kiebish
Thomas N Seyfried
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2005
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-5-102

Other articles of this Issue 1/2005

BMC Cancer 1/2005 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine